Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
A licence for the Cinergy QA module, which links Cyres Cytology and Cyres Colposcopy systems to provide end‑to‑end reporting and enable electronic submission of QA and KC dataset returns for the cervical screening programme.
Who is the supplier?
Cyres – the sole provider of the Cinergy system. No alternative suppliers or frameworks exist, so a Single Tender Action (STA) is the only viable route.
Why is it important?
Cinergy is the national system used by cervical screening laboratories and colposcopy clinics. SQAS requires access to review data, monitor performance, and quality assure the NHSCSP. Without Cinergy, SQAS cannot carry out statutory QA functions, risking inconsistent service quality and patient safety.
What are the risks if we do not purchase this?
SQAS unable to quality assure cervical screening services
Increased risk of avoidable cervical cancer due to lack of oversight
Sub‑optimal patient care and variation in
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Cyres Limited | 04321140 | £53,663 | 1 lot Lot 1 | - |
Taken from this notice, not from Companies House. Check the original notice — details change and are not updated here.
This procurement was divided into 1 lots, each awarded separately.
| Lot | Value | Awarded To | Status |
|---|---|---|---|
| Lot 1 | £53,663 initial term | Cyres Limited | active |
Government spending data: This supplier has received £274,020 in 10 payments (over £25k) from Manchester University NHS Foundation Trust, NHS England, Guy's and St Thomas' NHS FT (2020-02-17 to 2025-02-25). View full payment history →